Table 3.
The expression of tumor-associated indices/factors (n = 12)
Groups | CRP (µg/mL) | IL-2 (ng/mL) | VEGF (pg/mL) | IL-6 (ng/mL) | TNF-α (ng/mL) |
---|---|---|---|---|---|
Blank wafer | 1893.54 ± 172.42 | 1008.81 ± 105.77 | 1068.44 ± 247.05 | 147.39 ± 6.27 | 276.64 ± 38.21 |
ADS-I wafer (0.77 mg) | 1634.32 ± 293.49* | 1150.56 ± 214.65* | 877.66 ± 151.05 | 100.93 ± 20.37 | 218.08 ± 39.80* |
ADS-I wafer (1.53 mg) | 1525.44 ± 267.16** | 1193.64 ± 102.89* | 765.53 ± 149.86* | 89.40 ± 21.69* | 211.26 ± 31.44* |
ADS-I solution | 1886.08 ± 131.52 | 1112.59 ± 130.4 | 902.00 ± 127.35 | 132.82 ± 26.20* | 227.59 ± 47.34 |
The plasma levels of these tumor-associated factors were determined using ELISA kits. Statistical significant as compared to blank wafer group was determined by ANOVA.
p < 0.05;
p < 0.01.